Enterocolitis, Pseudomembranous
"Enterocolitis, Pseudomembranous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.
Descriptor ID |
D004761
|
MeSH Number(s) |
C01.252.410.222.310 C06.405.205.596.800 C06.405.469.363.800
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Enterocolitis, Pseudomembranous".
Below are MeSH descriptors whose meaning is more specific than "Enterocolitis, Pseudomembranous".
This graph shows the total number of publications written about "Enterocolitis, Pseudomembranous" by people in this website by year, and whether "Enterocolitis, Pseudomembranous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 0 | 1 |
2011 | 2 | 0 | 2 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2016 | 1 | 1 | 2 |
2017 | 19 | 4 | 23 |
2018 | 2 | 4 | 6 |
2019 | 4 | 2 | 6 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Enterocolitis, Pseudomembranous" by people in Profiles.
-
Cec and You Shall Find: Cecal Perforation in a Patient with COVID-19. Dig Dis Sci. 2021 11; 66(11):3731-3734.
-
Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem? Pol Arch Intern Med. 2021 02 26; 131(2):121-127.
-
Response to: Treatment of (Recurrent) Clostridioides difficile Infections in Children and Adults. J Pediatr Gastroenterol Nutr. 2019 08; 69(2):e58-e59.
-
Treatment of (recurrent) Clostridioides difficile Infections in Children and Adults. J Pediatr Gastroenterol Nutr. 2019 08; 69(2):e57-e58.
-
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. Gastroenterology. 2019 09; 157(3):682-691.e2.
-
2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg. 2019; 14:8.
-
Frequency of Positive Enzyme Immunoassay for Toxin in Stool of Asymptomatic Carriers of Clostridium difficile. Clin Infect Dis. 2019 02 01; 68(4):711.
-
Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease. Adv Chronic Kidney Dis. 2019 01; 26(1):30-34.
-
Bacterial Cocktail to Treat Clostridium difficile Infection: Primum Non Nocere. Clin Infect Dis. 2018 11 13; 67(11):1799.
-
Clinical heterogeneity of patients with stool samples testing PCR+/Tox- from a two-step Clostridium difficile diagnostic algorithm. Eur J Clin Microbiol Infect Dis. 2018 Dec; 37(12):2355-2359.